


Fibrotech
Portfolio Contact: Peter Devine Professor Darren Kelly Fibrotech is a spin-out of the University of Melbourne that developed drugs to treat fibrosis based on the work of Professor Darren Kelly. In April 2014, Fibrotech reached an agreement with Shire...
Hatchtech
Portfolio Contact: Peter DevineWebsite: www.hatchtech.com.au This investment won the Australian Venture Capital Association ‘Best Early Stage Venture Deal of 2016’ and Hatchtech’s human head lice treatment received FDA approval in July...
Fultec
Portfolio Contact: Peter Devine The Fultec device is a protection switch that virtually instantaneously disconnects vulnerable equipment from the disturbed input power terminal and then reconnects the system after the surge has passed. The device offers...
Recent Comments